B12 $199 $65 one-month supply Improves energy, boosts metabolism, helps burn fat
However, human clinical evidence is still limited, and larger, well-controlled trials are needed to clarify safety, efficacy, and appropriate use
REDEFINE 2 ClinicalTrials.gov number, NCT05394519.) Cagrilintide-Semaglutide for Overweight and Diabetes In this phase 3a trial involving adults with obesity and diabetes, the use of cagrilintide-semaglutide resulted in a significantly lower body weight than placebo at 68 weeks.
The Risk-Benefit Equation Potential benefits: Faster healing (unproven in humans) Known risks: Immune reactions Impurities and contamination Unknown side effects Legal consequences (athletes) Cancer promotion (theoretical) Wasting money on snake oil Verdict: Risk outweighs unproven benefit
For Laboratory Research Use Only (RUO)